| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Coactivator, through Proline-, Glutamic Acid-, and Leucine-Rich Protein-1 (PELP1)Molecular and Cellular Oncology (A.E.G., S.P., R.K.), The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030; Obstetrics and Gynecology (R.K.V.), University of Texas Health Science Center at San Antonio, San Antonio, Texas 78229; and Molecular and Cellular Biology (R.K.), Baylor College of Medicine, Houston, Texas 77030
Address all correspondence and requests for reprints to: Rakesh Kumar, Molecular and Cellular Oncology, Unit 108, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030. E-mail: rkumar{at}mdanderson.org.
We recently reported that the breast carcinoma amplified sequence-3 (BCAS3) gene is regulated by estrogen receptor (ER)
. However, the role of ER
coactivators in the regulation of BCAS3 expression remains unknown, and information regarding the function of the BCAS3 protein is lacking. Here, we define the contribution of ER
coactivators to BCAS3 regulation and identify BCAS3 itself as an ER
coactivator in breast cancer cells. We found that PELP1 (proline-, glutamic acid-, and leucine-rich protein-1), a newly described ER
coregulator, is recruited to BCAS3 chromatin and activates its expression. Analysis of the BCAS3 sequence for functional motifs and evidence from biochemical fractionation suggested that BCAS3 acts as a transcriptional coactivator. Results from chromatin immunoprecipitation, reporter assays, and expression studies further validated the coactivator function of BCAS3 for ER
. BCAS3 physically associated with histone H3 and histone acetyltransferase complex protein P/CAF (p300/CBP-associated factor) and possessed histone acetyltransferase activity. Unexpectedly, BCAS3 required PELP1 to function as a coactivator in ER
transactivation activity. In brief, these results highlight a mechanism whereby ER
activation triggers a positive feedback loop leading to signal amplification in the cell.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
B. W. O'Malley and R. Kumar Nuclear Receptor Coregulators in Cancer Biology Cancer Res., November 1, 2009; 69(21): 8217 - 8222. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |